The Indian Pharmacopoeia Commission (IPC) will soon amend the heparin sodium monograph in IP 2018 following an appeal from stakeholders. The decision to this effect was taken by the IPC at a meeting ...

The Indian Pharmacopoeia Commission (IPC) has asked stakeholders to provide comments and recommendations to amend the heparin sodium monograph in IP 2018 for COVID-19 management within 45 days at ...